Bragg Financial Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $299K | Sell |
3,308
-105
| -3% | -$8.8K | 0.01% | 335 |
|
|
2026
Q1 | $273K | Buy |
3,413
+24
| +0.7% | +$1.98K | 0.01% | 329 |
|
|
2025
Q4 | $289K | Sell |
3,389
-179
| -5% | -$14.7K | 0.01% | 314 |
|
|
2025
Q3 | $277K | Hold |
3,568
| – | – | 0.01% | 315 |
|
|
2025
Q2 | $279K | Buy |
3,568
+3
| +0.1% | +$224 | 0.01% | 308 |
|
|
2025
Q1 | $258K | Sell |
3,565
-41
| -1% | -$2.94K | 0.01% | 310 |
|
|
2024
Q4 | $267K | Hold |
3,606
| – | – | 0.01% | 305 |
|
|
2024
Q3 | $238K | Sell |
3,606
-438
| -11% | -$31.8K | 0.01% | 310 |
|
|
2024
Q2 | $374K | Hold |
4,044
| – | – | 0.02% | 261 |
|
|
2024
Q1 | $386K | Hold |
4,044
| – | – | 0.02% | 262 |
|
|
2023
Q4 | $308K | Hold |
4,044
| – | – | 0.01% | 274 |
|
|
2023
Q3 | $280K | Hold |
4,044
| – | – | 0.01% | 288 |
|
|
2023
Q2 | $381K | Hold |
4,044
| – | – | 0.02% | 262 |
|
|
2023
Q1 | $335K | Hold |
4,044
| – | – | 0.02% | 268 |
|
|
2022
Q4 | $302K | Sell |
4,044
-1,263
| -24% | -$97.3K | 0.02% | 272 |
|
|
2022
Q3 | $439K | Sell |
5,307
-442
| -8% | -$42.5K | 0.03% | 232 |
|
|
2022
Q2 | $547K | Sell |
5,749
-256
| -4% | -$26.5K | 0.04% | 221 |
|
|
2022
Q1 | $707K | Buy |
6,005
+13
| +0.2% | +$1.46K | 0.04% | 205 |
|
|
2021
Q4 | $678K | Hold |
5,992
| – | – | 0.04% | 198 |
|
|
2021
Q3 | $678K | Buy |
5,992
+84
| +1% | +$9.59K | 0.04% | 198 |
|
|
2021
Q2 | $612K | Sell |
5,908
-42
| -0.7% | -$3.96K | 0.04% | 207 |
|
|
2021
Q1 | $498K | Sell |
5,950
-437
| -7% | -$36.9K | 0.03% | 215 |
|
|
2020
Q4 | $583K | Buy |
6,387
+66
| +1% | +$5.47K | 0.05% | 193 |
|
|
2020
Q3 | $505K | Sell |
6,321
-210
| -3% | -$16.4K | 0.05% | 190 |
|
|
2020
Q2 | $451K | Sell |
6,531
-975
| -13% | -$69.3K | 0.05% | 193 |
|
|
2020
Q1 | $472K | Hold |
7,506
| – | – | 0.06% | 181 |
|
|
2019
Q4 | $584K | Sell |
7,506
-192
| -2% | -$15K | 0.07% | 186 |
|
|
2019
Q3 | $564K | Hold |
7,698
| – | – | 0.07% | 189 |
|
|
2019
Q2 | $474K | Hold |
7,698
| – | – | 0.06% | 199 |
|
|
2019
Q1 | $491K | Hold |
7,698
| – | – | 0.06% | 192 |
|
|
2018
Q4 | $393K | Hold |
7,698
| – | – | 0.06% | 198 |
|
|
2018
Q3 | $447K | Buy |
7,698
+111
| +1% | +$5.43K | 0.06% | 196 |
|
|
2018
Q2 | $368K | Hold |
7,587
| – | – | 0.05% | 211 |
|
|
2018
Q1 | $353K | Hold |
7,587
| – | – | 0.05% | 221 |
|
|
2017
Q4 | $285K | Hold |
7,587
| – | – | 0.04% | 234 |
|
|
2017
Q3 | $276K | Hold |
7,587
| – | – | 0.04% | 233 |
|
|
2017
Q2 | $299K | Buy |
+7,587
| New | +$277K | 0.05% | 237 |
|
|
2016
Q4 | – | Sell |
-5,556
| Closed | -$223K | – | 255 |
|
|
2016
Q3 | $223K | Buy |
+5,556
| New | +$209K | 0.04% | 242 |
|
Other funds holding EW
Bragg Financial Advisors's EW Position: Q2 2026 in Review
Bragg Financial Advisors reduced its Edwards Lifesciences (EW) stake by 3.1% in Q2 2026, selling an estimated $8.8K and leaving 3,308 shares worth $299K. The position accounts for 0.01% of the portfolio, ranked #335.
Bragg Financial Advisors first reported a position in EW in Q3 2016 and has held it in 38 quarters since. The position peaked at $707K in Q1 2022. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Bragg Financial Advisors held 3,308 shares of Edwards Lifesciences worth $299K as of Q2 2026.
- Bragg Financial Advisors sold 105 Edwards Lifesciences shares in Q2 2026, an estimated $8.8K.
- Edwards Lifesciences made up 0.01% of Bragg Financial Advisors's portfolio in Q2 2026, its #335 holding.
- Bragg Financial Advisors first reported a position in Edwards Lifesciences in Q3 2016 and has held it in 38 quarters since.
- Bragg Financial Advisors's Edwards Lifesciences position peaked at $707K in Q1 2022.
- 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Bragg Financial Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.